Stay updated on Benralizumab in HES: Efficacy and Safety Clinical Trial
Sign up to get notified when there's something new on the Benralizumab in HES: Efficacy and Safety Clinical Trial page.

Latest updates to the Benralizumab in HES: Efficacy and Safety Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA revision tag was updated from v3.6.3 to v3.6.4, representing an update to the document version used on the study page. This is an administrative versioning change to the study materials.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedResults posted status added and locations expanded to 52 (including Shanghai, China); the page now shows additional DB-period endpoints and data descriptions, reflecting the updated results dataset.SummaryDifference3%

- Check30 days agoChange DetectedPublications section updated to show the final Nat Med citation for the NATRON study with Jun 2026 publication details and full DOI, replacing the previous online-ahead-of-print entry. This clarifies attribution and the publication status of the study in the Publications section.SummaryDifference0.0%

- Check37 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.3, signaling a newer version of the page. It appears to be a minor administrative update with no changes to trial data or study details.SummaryDifference0.0%

- Check51 days agoChange DetectedDifference0.3%

- Check58 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5 in the page footer, signaling a minor software/template update. No clinical trial data or study details are altered.SummaryDifference0.0%

Stay in the know with updates to Benralizumab in HES: Efficacy and Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Benralizumab in HES: Efficacy and Safety Clinical Trial page.